Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Elaine Ullian. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Elaine Ullian har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:VRTX / Vertex Pharmaceuticals Incorporated | Director | 6 659 |
US:TMO / Thermo Fisher Scientific Inc. | Director | 4 706 |
US:HOLX / Hologic, Inc. | Director | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Elaine Ullian. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Elaine Ullian som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2019-06-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 6 659 | 6 659 | |||||
2019-05-23 |
|
4 | TMO |
THERMO FISHER SCIENTIFIC INC.
Common Stock |
A - Award | 718 | 4 706 | 18,00 | ||||
2018-08-08 |
|
4 | TMO |
THERMO FISHER SCIENTIFIC INC.
Common Stock |
G - Gift | −858 | 7 626 | −10,11 | ||||
2018-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 3 229 | 3 229 | |||||
2018-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 1 801 | 12 195 | 17,33 | ||||
2018-05-24 |
|
4 | TMO |
THERMO FISHER SCIENTIFIC INC.
Common Stock |
A - Award | 809 | 8 484 | 10,54 | ||||
2017-11-15 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −3 492 | 0 | −100,00 | |||
2017-11-15 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | X | 3 492 | 27 302 | 14,67 | 18,82 | 65 719 | 513 824 |
2017-11-15 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −9 282 | 3 492 | −72,66 | |||
2017-11-15 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
S - Sale | X | −9 282 | 23 810 | −28,05 | 40,50 | −375 921 | 964 305 |
2017-11-15 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | X | 9 282 | 33 092 | 38,98 | 18,82 | 174 687 | 622 791 |
2017-10-25 |
|
5 | HOLX |
HOLOGIC INC
Common Stock |
G - Gift | −998 | 23 810 | −4,02 | ||||
2017-08-07 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −998 | 0 | −100,00 | |||
2017-08-07 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | X | 998 | 24 808 | 4,19 | 32,82 | 32 749 | 814 075 |
2017-08-07 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −6 902 | 998 | −87,37 | |||
2017-08-07 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
S - Sale | X | −6 902 | 23 810 | −22,47 | 40,12 | −276 908 | 955 257 |
2017-08-07 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | X | 6 902 | 30 712 | 28,99 | 32,82 | 226 489 | 1 007 814 |
2017-08-07 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
G - Gift | −1 451 | 23 810 | −5,74 | ||||
2017-07-06 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −1 451 | 7 900 | −15,52 | |||
2017-07-06 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | X | 1 451 | 25 261 | 6,09 | 32,82 | 47 615 | 828 940 |
2017-07-06 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −8 849 | 9 351 | −48,62 | |||
2017-07-06 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
S - Sale | X | −8 849 | 23 810 | −27,10 | 45,28 | −400 674 | 1 078 093 |
2017-07-06 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | X | 8 849 | 32 659 | 37,17 | 32,82 | 290 380 | 1 071 705 |
2017-07-06 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
G - Gift | −1 362 | 23 810 | −5,41 | ||||
2017-06-06 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −1 362 | 18 200 | −6,96 | |||
2017-06-06 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | X | 1 362 | 25 172 | 5,72 | 32,82 | 44 694 | 826 019 |
2017-06-06 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −8 938 | 19 562 | −31,36 | |||
2017-06-06 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
S - Sale | X | −8 938 | 23 810 | −27,29 | 43,99 | −393 183 | 1 047 402 |
2017-06-06 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | X | 8 938 | 32 748 | 37,54 | 32,82 | 293 300 | 1 074 626 |
2017-06-06 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
G - Gift | −1 444 | 23 810 | −5,72 | ||||
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 5 295 | 5 295 | |||||
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 2 188 | 10 394 | 26,66 | ||||
2017-05-19 |
|
4 | TMO |
THERMO FISHER SCIENTIFIC INC.
Common Stock |
A - Award | 1 024 | 7 675 | 15,40 | ||||
2017-05-05 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −1 444 | 28 500 | −4,82 | |||
2017-05-05 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | X | 1 444 | 25 254 | 6,06 | 32,82 | 47 385 | 828 710 |
2017-05-05 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −8 856 | 29 944 | −22,82 | |||
2017-05-05 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
S - Sale | X | −8 856 | 23 810 | −27,11 | 45,09 | −399 317 | 1 073 593 |
2017-05-05 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | X | 8 856 | 32 666 | 37,19 | 32,82 | 290 610 | 1 071 935 |
2017-05-05 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
G - Gift | −1 196 | 23 810 | −4,78 | ||||
2017-04-05 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −1 196 | 38 800 | −2,99 | |||
2017-04-05 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | X | 1 196 | 34 110 | 3,63 | 32,82 | 39 247 | 1 119 320 |
2017-04-05 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −9 104 | 39 996 | −18,54 | |||
2017-04-05 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
S - Sale | X | −9 104 | 23 810 | −27,66 | 42,40 | −386 010 | 1 009 544 |
2017-04-05 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | X | 9 104 | 32 914 | 38,24 | 32,82 | 298 748 | 1 080 073 |
2017-04-05 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
G - Gift | −11 668 | 23 810 | −32,89 | ||||
2017-03-09 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
A - Award | 9 027 | 9 027 | |||||
2017-03-09 |
|
4 | HOLX |
HOLOGIC INC
Restricted Stock Unit Award (Right To Receive) |
M - Exercise | −3 260 | 0 | −100,00 | ||||
2017-03-09 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | 3 260 | 35 478 | 10,12 | ||||
2017-03-09 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
A - Award | 2 922 | 32 218 | 9,97 | ||||
2017-03-07 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −1 044 | 49 100 | −2,08 | |||
2017-03-07 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | X | 1 044 | 29 296 | 3,70 | 32,82 | 34 259 | 961 348 |
2017-03-07 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −9 256 | 50 144 | −15,58 | |||
2017-03-07 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
S - Sale | X | −9 256 | 28 252 | −24,68 | 40,82 | −377 830 | 1 153 247 |
2017-03-07 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | X | 9 256 | 37 508 | 32,76 | 32,82 | 303 736 | 1 230 825 |
2017-02-07 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | −877 | 59 400 | −1,45 | ||||
2017-02-07 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | 877 | 28 252 | 3,20 | 32,82 | 28 779 | 927 089 | |
2017-02-07 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | −9 423 | 60 277 | −13,52 | ||||
2017-02-07 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
S - Sale | X | −9 423 | 27 375 | −25,61 | 39,54 | −372 585 | 1 082 408 |
2017-02-07 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | 9 423 | 36 798 | 34,42 | 32,82 | 309 216 | 1 207 526 | |
2017-01-05 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | −949 | 69 700 | −1,34 | ||||
2017-01-05 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | 949 | 27 375 | 3,59 | 32,82 | 31 141 | 898 311 | |
2017-01-05 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | −9 351 | 70 649 | −11,69 | ||||
2017-01-05 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
S - Sale | X | −9 351 | 26 426 | −26,14 | 40,00 | −374 040 | 1 057 040 |
2017-01-05 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | 9 351 | 35 777 | 35,39 | 32,82 | 306 853 | 1 174 022 | |
2016-10-12 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | −1 764 | 80 000 | −2,16 | ||||
2016-10-12 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | 1 764 | 26 426 | 7,15 | 32,82 | 57 886 | 867 169 | |
2016-10-12 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | −18 236 | 81 764 | −18,24 | ||||
2016-10-12 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
S - Sale | X | −18 236 | 24 662 | −42,51 | 39,88 | −727 270 | 983 545 |
2016-10-12 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | 18 236 | 42 898 | 73,94 | 32,82 | 598 414 | 1 407 698 | |
2016-06-21 |
|
4 | HOLX |
HOLOGIC INC
Restricted Stock Unit Award (Right To Receive) |
M - Exercise | −401 | 0 | −100,00 | ||||
2016-06-21 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | 401 | 24 662 | 1,65 | ||||
2016-06-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 7 073 | 7 073 | |||||
2016-06-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 2 941 | 8 206 | 55,86 | 0,01 | 29 | 82 | |
2016-05-31 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | −16 071 | 0 | −100,00 | ||||
2016-05-31 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
S - Sale | −6 896 | 24 261 | −22,13 | 33,85 | −233 430 | 821 235 | |
2016-05-31 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | 16 071 | 31 157 | 106,53 | 14,50 | 233 030 | 451 776 | |
2016-05-20 |
|
4 | TMO |
THERMO FISHER SCIENTIFIC INC.
Common Stock |
A - Award | 1 000 | 6 651 | 17,70 | ||||
2016-03-04 |
|
4 | HOLX |
HOLOGIC INC
Restricted Stock Unit Award (Right To Receive) |
A - Award | 3 260 | 3 260 | |||||
2016-03-04 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
A - Award | 9 940 | 9 940 | |||||
2016-01-05 |
|
4 | HOLX |
HOLOGIC INC
Restricted Stock Unit Award (Right To Receive) |
M - Exercise | −3 272 | 0 | −100,00 | ||||
2016-01-05 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | 3 272 | 15 086 | 27,70 | ||||
2015-12-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −22 500 | 0 | −100,00 | ||||
2015-12-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 5 265 | −1,86 | 131,38 | −13 138 | 691 716 |
2015-12-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 400 | 5 365 | −50,16 | 130,68 | −705 672 | 701 098 |
2015-12-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 711 | 10 765 | −49,87 | 129,77 | −1 389 966 | 1 396 974 |
2015-12-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −6 289 | 21 476 | −22,65 | 128,78 | −809 897 | 2 765 679 |
2015-12-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 22 500 | 27 765 | 427,35 | 59,55 | 1 339 875 | 1 653 406 | |
2015-11-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2015-11-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 100 | 5 265 | −28,51 | 127,62 | −268 002 | 671 919 |
2015-11-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −6 708 | 7 365 | −47,67 | 126,91 | −851 312 | 934 692 |
2015-11-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −9 592 | 14 073 | −40,53 | 125,98 | −1 208 400 | 1 772 917 |
2015-11-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −700 | 23 665 | −2,87 | 125,09 | −87 563 | 2 960 255 |
2015-11-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −900 | 24 365 | −3,56 | 123,66 | −111 294 | 3 012 976 |
2015-11-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 20 000 | 25 265 | 379,87 | 53,85 | 1 077 000 | 1 360 520 | |
2015-10-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2015-10-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −20 000 | 5 265 | −79,16 | 110,00 | −2 200 000 | 579 150 |
2015-10-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 20 000 | 25 265 | 379,87 | 34,24 | 684 800 | 865 074 | |
2015-07-30 |
|
4 | TMO |
THERMO FISHER SCIENTIFIC INC.
Common Stock |
G - Gift | −4 400 | 5 651 | −43,78 | ||||
2015-06-19 |
|
4 | HOLX |
HOLOGIC INC
Restricted Stock Unit Award (Right To Receive) |
A - Award | 401 | 401 | |||||
2015-06-19 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
A - Award | 1 109 | 1 109 | |||||
2015-06-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 22 500 | 22 500 | |||||
2015-05-22 |
|
4 | TMO |
THERMO FISHER SCIENTIFIC INC.
Common Stock |
A - Award | 1 137 | 10 051 | 12,76 | ||||
2015-02-13 |
|
5 | TMO |
THERMO FISHER SCIENTIFIC INC.
Common Stock |
G - Gift | −4 245 | 8 914 | −32,26 | ||||
2015-01-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2015-01-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 5 265 | −1,86 | 123,57 | −12 357 | 650 596 |
2015-01-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 100 | 5 365 | −36,62 | 122,96 | −381 176 | 659 680 |
2015-01-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 700 | 8 465 | −16,72 | 122,15 | −207 655 | 1 034 000 |
2015-01-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 10 165 | −0,97 | 118,91 | −11 891 | 1 208 720 |
2015-01-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 5 000 | 10 265 | 94,97 | 34,32 | 171 600 | 352 295 | |
2015-01-05 |
|
4 | HOLX |
HOLOGIC INC
Restricted Stock Unit Award (Right To Receive) |
M - Exercise | −3 914 | 0 | −100,00 | ||||
2015-01-05 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
A - Award | 9 039 | 9 039 | |||||
2015-01-05 |
|
4 | HOLX |
HOLOGIC INC
Restricted Stock Unit Award (Right To Receive) |
A - Award | 3 272 | 3 272 | |||||
2015-01-05 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | 3 914 | 11 814 | 49,54 | 26,74 | 104 660 | 315 906 | |
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −5 000 | 5 000 | −50,00 | ||||
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 5 265 | −1,86 | 111,57 | −11 157 | 587 416 |
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 5 365 | −1,83 | 110,45 | −11 045 | 592 564 |
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −300 | 5 465 | −5,20 | 109,30 | −32 790 | 597 324 |
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 100 | 5 765 | −16,02 | 108,32 | −119 152 | 624 465 |
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 592 | 6 865 | −27,41 | 107,48 | −278 588 | 737 850 |
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −808 | 9 457 | −7,87 | 106,42 | −85 987 | 1 006 414 |
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 5 000 | 10 265 | 94,97 | 34,32 | 171 600 | 352 295 | |
2014-09-09 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
P - Purchase | 7 900 | 7 900 | 25,36 | 200 344 | 200 344 | ||
2014-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −5 000 | 10 000 | −33,33 | ||||
2014-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 800 | 5 265 | −47,69 | 95,26 | −457 248 | 501 544 |
2014-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −200 | 10 065 | −1,95 | 94,09 | −18 818 | 947 016 |
2014-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 5 000 | 10 265 | 94,97 | 34,32 | 171 600 | 352 295 | |
2014-06-26 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
G - Gift | −6 007 | 0 | −100,00 | ||||
2014-06-26 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
G - Gift | −24 026 | 6 007 | −80,00 | ||||
2014-06-11 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −2 500 | 15 000 | −14,29 | ||||
2014-06-11 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 500 | 5 265 | −32,20 | 75,00 | −187 500 | 394 875 |
2014-06-11 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 500 | 7 765 | 47,48 | 34,32 | 85 800 | 266 495 | |
2014-06-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 22 500 | 22 500 | |||||
2014-05-22 |
|
4 | TMO |
THERMO FISHER SCIENTIFIC INC.
Common Stock |
A - Award | 1 311 | 13 159 | 11,07 | ||||
2014-05-07 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | −7 936 | 0 | −100,00 | ||||
2014-05-07 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | −9 945 | 7 936 | −55,62 | ||||
2014-05-07 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
S - Sale | −9 945 | 30 033 | −24,88 | 23,60 | −234 702 | 708 779 | |
2014-05-07 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | 9 945 | 39 978 | 33,11 | 13,07 | 129 981 | 522 512 | |
2014-05-07 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
M - Exercise | 7 936 | 30 033 | 35,91 | 13,07 | 103 724 | 392 531 | |
2014-04-11 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option(right to buy) |
M - Exercise | −2 500 | 17 500 | −12,50 | ||||
2014-04-11 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 500 | 5 265 | −32,20 | 70,00 | −175 000 | 368 550 |
2014-04-11 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 500 | 7 765 | 47,48 | 34,32 | 85 800 | 266 495 | |
2014-01-03 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
A - Award | 11 146 | 11 146 | |||||
2014-01-03 |
|
4 | HOLX |
HOLOGIC INC
Restricted Stock Unit Award (Right To Receive) |
A - Award | 3 914 | 3 914 | |||||
2013-06-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 22 500 | 22 500 | |||||
2013-05-24 |
|
4 | TMO |
THERMO FISHER SCIENTIFIC INC.
Common Stock |
A - Award | 1 739 | 11 848 | 17,20 | ||||
2013-05-08 |
|
4 | TMO |
THERMO FISHER SCIENTIFIC INC.
Common Stock |
S - Sale | −8 000 | 10 109 | −44,18 | 82,73 | −661 840 | 836 318 | |
2013-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2013-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2013-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | −40 000 | 5 265 | −88,37 | 77,99 | −3 119 600 | 410 617 | |
2013-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 20 000 | 45 265 | 79,16 | 29,89 | 597 800 | 1 352 971 | |
2013-05-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 20 000 | 25 265 | 379,87 | 29,84 | 596 800 | 753 908 | |
2013-01-03 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
A - Award | 12 306 | 12 306 | |||||
2013-01-03 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
A - Award | 4 372 | 22 097 | 24,67 | ||||
2012-11-15 |
|
4 | TMO |
THERMO FISHER SCIENTIFIC INC.
Stock Option (Right to Buy) |
M - Exercise | −10 500 | 0 | −100,00 | ||||
2012-11-15 |
|
4 | TMO |
THERMO FISHER SCIENTIFIC INC.
Stock Option (Right to Buy) |
M - Exercise | −15 600 | 0 | −100,00 | ||||
2012-11-15 |
|
4 | TMO |
THERMO FISHER SCIENTIFIC INC.
Common Stock |
S - Sale | −26 100 | 18 109 | −59,04 | 61,51 | −1 605 411 | 1 113 885 | |
2012-11-15 |
|
4 | TMO |
THERMO FISHER SCIENTIFIC INC.
Common Stock |
M - Exercise | 10 500 | 44 209 | 31,15 | 36,75 | 385 875 | 1 624 681 | |
2012-11-15 |
|
4 | TMO |
THERMO FISHER SCIENTIFIC INC.
Common Stock |
M - Exercise | 15 600 | 33 709 | 86,15 | 43,37 | 676 572 | 1 461 959 | |
2012-06-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 22 500 | 22 500 | |||||
2012-05-25 |
|
4 | TMO |
THERMO FISHER SCIENTIFIC INC.
Common Stock |
A - Award | 2 452 | 18 109 | 15,66 | ||||
2012-05-11 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2012-05-11 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | −20 000 | 5 265 | −79,16 | 60,58 | −1 211 600 | 318 954 | |
2012-05-11 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 20 000 | 25 265 | 379,87 | 28,40 | 568 000 | 717 526 | |
2012-05-01 |
|
4 | TMO |
THERMO FISHER SCIENTIFIC INC.
Stock Option (Right to Buy) |
M - Exercise | −7 500 | 0 | −100,00 | ||||
2012-05-01 |
|
4 | TMO |
THERMO FISHER SCIENTIFIC INC.
Common Stock |
S - Sale | −7 500 | 15 657 | −32,39 | 55,22 | −414 150 | 864 580 | |
2012-05-01 |
|
4 | TMO |
THERMO FISHER SCIENTIFIC INC.
Common Stock |
M - Exercise | 7 500 | 23 157 | 47,90 | 26,53 | 198 975 | 614 355 | |
2012-02-07 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
S - Sale | −4 649 | 17 725 | −20,78 | 20,71 | −96 281 | 367 085 | |
2012-01-04 |
|
4 | HOLX |
HOLOGIC INC
Non-qualified Stock Option (Right to Buy) |
A - Award | 13 257 | 13 257 | |||||
2012-01-04 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
A - Award | 4 997 | 22 374 | 28,76 | ||||
2009-01-05 |
|
4 | HOLX |
HOLOGIC INC
Non-Qualified Stock Option (right to buy) |
A - Award | 17 881 | 17 881 | |||||
2009-01-05 |
|
4 | HOLX |
HOLOGIC INC
Common Stock |
A - Award | 6 694 | 6 694 |